Toward fully algorithmic care for type 1 diabetes: The case for AI autonomy, and a recalibrated role for the diabetologist in an ageing type 2 diabetes population.

Artificial intelligence can already automate selected diabetes tasks, but the evidence is uneven. Automated insulin delivery is established in type 1 diabetes; in type 2 diabetes, validated screening and insulin-adjustment tools support a tiered, human-governed model rather than wholesale autonomy.